Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1381 (LINC01381) is a long intergenic non-coding RNA (lincRNA) gene that produces a non-protein-coding transcript[1][4][7]. LINC01381 is also annotated as DNMT3A antisense downstream transcript and TCONS_00002860. LincRNAs like LINC01381 do not encode proteins but can participate in regulatory functions, including chromatin remodeling, gene expression regulation, and possibly modulation of the expression of neighboring or antisense genes such as DNMT3A[1][4][7]. The specific biological function and disease association for LINC01381 have not been characterized in detail, and there are no reports supporting its direct involvement in human disease or its use as a therapeutic target, drug interaction partner, or clinically relevant biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1381 (LINC01381).